Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Abdominal Injuries

glucose, (beta-d)-isomer has been researched along with Abdominal Injuries in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alcaraz, MJ; Charris, J; De León, EJ; Dominguez, JN; Terencio, MC1
Bland, KI; Chaudry, IH; Choudhry, MA; Fujimi, S; Kawasaki, T; Lederer, JA; Schwacha, MG1

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Abdominal Injuries

ArticleYear
A new chloroquinolinyl chalcone derivative as inhibitor of inflammatory and immune response in mice and rats.
    The Journal of pharmacy and pharmacology, 2003, Volume: 55, Issue:9

    Topics: Abdominal Injuries; Administration, Oral; Animals; Arthritis, Experimental; Blood Platelets; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Dinitrofluorobenzene; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Formaldehyde; Group II Phospholipases A2; Group IV Phospholipases A2; Humans; Inflammation; Lipopolysaccharides; Lymphocyte Activation; Macrophages; Mice; Microsomes; Nitrites; Pain; Pain Measurement; Phospholipases A; Pyridazines; Rats; Rats, Inbred Lew; Thromboxane B2; Zymosan

2003
Trauma-hemorrhage inhibits splenic dendritic cell proinflammatory cytokine production via a mitogen-activated protein kinase process.
    American journal of physiology. Cell physiology, 2008, Volume: 294, Issue:3

    Topics: Abdomen; Abdominal Injuries; Animals; Cells, Cultured; Cytokines; Dendritic Cells; Disease Models, Animal; Down-Regulation; Enzyme Activation; Hemorrhage; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Lymphocyte Antigen 96; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Spleen; Time Factors; Toll-Like Receptor 2; Toll-Like Receptor 4; Zymosan

2008